Clinical Trials on Hemoglobin C Disease in Switzerland
Total 7509 results
-
Swiss Federal Institute of Sport MagglingenUnknownHemoglobinsSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedFemale Genital Mutilation / Cutting (FGM/C)Switzerland
-
Bristol-Myers SquibbBasel Institute of Clinical Epidemiology (BICE)Completed
-
Pevion Biotech LtdCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
Kantonsspital OltenCompletedPulmonary Artery Hypertension | Chronic Hepatitis cSwitzerland
-
University Hospital, GenevaGastaldi Giacomo; Clément SophieCompleted
-
University Hospital, GenevaCompletedChronic Hepatitis CSwitzerland
-
University of ZurichPD Dr. rer. nat. Mathias HeikenwälderUnknown
-
University of OxfordGlaxoSmithKline; Cantonal Hospital of St. Gallen; St. James's Hospital, Ireland; ReiThera SrlCompletedHepatitis C InfectionSwitzerland, Ireland
-
University of BernRoche Pharma AG; University of Lausanne; University of Basel; Cantonal Hospital... and other collaboratorsCompleted
-
AbbVieCompleted
-
University of ZurichCompleted
-
University of ZurichLuzerner Kantonsspital; Kantonsspital Winterthur KSW; Cantonal Hosptal, Baselland and other collaboratorsRecruitingSupport of Colonization Resistance of the Gut Microbiota With the Synbiotic Food Supplement Nagasin®C. Difficile EnteritisSwitzerland
-
Janssen Pharmaceutica N.V., BelgiumCompletedHepatitis, ChronicFrance, United Kingdom, Belgium, Germany, Netherlands, Switzerland
-
Gilead SciencesCompletedHepatitis C Virus InfectionSpain, Switzerland, United Kingdom
-
Boehringer IngelheimCompletedHepatitis C, ChronicFrance, Germany, Switzerland
-
Cytheris SAUnknownHepatitis CFrance, Switzerland, Italy
-
Cytheris SACompletedHepatitis CFrance, Switzerland, Italy
-
Kirby InstituteMerck Sharp & Dohme LLCCompletedHepatitis C, ChronicAustralia, Canada, United Kingdom, Belgium, Germany, Norway, Switzerland
-
Novartis PharmaceuticalsTerminatedHepatitis C | Liver TransplantUnited States, Switzerland
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Kirby InstituteCompletedHepatitis C, ChronicUnited States, United Kingdom, Australia, France, New Zealand, Canada, Switzerland, Germany
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Australia, Austria, France, Germany, New Zealand, Portugal, Romania, Spain, Switzerland
-
Bristol-Myers SquibbCompletedHepatitis CAustralia, France, Germany, Italy, United Kingdom, United States, Canada, Poland, Austria, Denmark, Israel, Spain, Russian Federation, Switzerland, Argentina, Brazil
-
Janssen Infectious Diseases BVBAVertex Pharmaceuticals IncorporatedCompletedHepatitis C, ChronicUnited States, Australia, United Kingdom, Germany, France, Spain, Belgium, Netherlands, Canada, Brazil, Puerto Rico, Poland, Sweden, Switzerland, Israel
-
Janssen-Cilag International NVNo longer availableHepatitis CAustralia, Belgium, Germany, Spain, Switzerland, Romania, Serbia, Greece, New Zealand, Brazil, Russian Federation, Austria, Hungary, Czech Republic, Luxembourg
-
AbbVieCompletedHepatitis CAustria, Belgium, France, Greece, Israel, Italy, Poland, Portugal, Switzerland
-
Bristol-Myers SquibbCompletedHepatitis C VirusUnited States, Germany, Italy, Korea, Republic of, Sweden, Russian Federation, Canada, France, Argentina, Switzerland, Denmark, Taiwan, Netherlands, Spain, Mexico
-
Bristol-Myers SquibbCompletedHepatitis C VirusBelgium, Germany, Spain, United States, Canada, Brazil, Austria, France, Israel, Switzerland, Italy, Russian Federation, Czechia, Poland, United Kingdom
-
AbbVieCompletedHepatitis C Virus InfectionUnited States, Australia, Canada, China, Germany, Korea, Republic of, New Zealand, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Brazil, France, Germany, Italy, Spain, Switzerland, United Kingdom
-
Hoffmann-La RocheCompletedHepatitis C, ChronicBelgium, France, Germany, Italy, Spain, Sweden, United States, Greece, Portugal, Turkey, Switzerland, Canada, United Kingdom, Brazil
-
Hoffmann-La RocheCompletedHepatitis C, ChronicBelgium, United States, Germany, Canada, Austria, Switzerland, Puerto Rico, Australia, Brazil, Mexico
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Austria, Belgium, Canada, France, Germany, Japan, Portugal, Puerto Rico, Spain, Switzerland, United Kingdom
-
Tibotec BVBATibotec Pharmaceutical LimitedCompletedHepatitis C, ChronicUnited States, Australia, France, United Kingdom, Germany, Spain, Belgium, Israel, Canada, Brazil, Austria, Poland, Netherlands, Sweden, Switzerland, Puerto Rico
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Argentina, Australia, Austria, Canada, Czech Republic, France, Germany, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Switzerland, United Kingdom
-
Hoffmann-La RocheCompletedHepatitis C, ChronicBelgium, France, Germany, Sweden, Switzerland, Turkey, Greece, Taiwan, Estonia, Slovakia, Italy, Romania, Lithuania, Serbia, Portugal, Egypt, Pakistan, Mexico, Peru, Lebanon, United States, Argentina, Chile, Kuwait, Latvia, Macedonia, The... and more
-
Hoffmann-La RocheCompletedHepatitis C, ChronicBelgium, France, Germany, Sweden, Switzerland, Turkey, Greece, Ireland, Taiwan, Estonia, Hungary, Italy, Romania, United Kingdom, Serbia, Morocco, Portugal, Saudi Arabia, Egypt, Pakistan, Lebanon, Macedonia, The Former Yugoslav Republic... and more
-
ETOP IBCSG Partners FoundationRoche Pharma AGActive, not recruitingEGFRmutant Stage IIIB/C or IV Non-squamous NSCLCSingapore, Spain, Korea, Republic of, Switzerland, Germany
-
Philogen S.p.A.RecruitingMelanoma Stage IIIB/CSpain, United States, Switzerland
-
AstraZenecaTerminatedElevated High-sensitivity C-Reactive Protein (hsCRP)United States, Brazil, Bulgaria, Poland, Russian Federation, South Africa, United Kingdom, Germany, Estonia, Romania, Denmark, Netherlands, Norway, Canada, Mexico, Belgium, Israel, Puerto Rico, Colombia, Argentina, Venezuela, Panama, Urugu... and more
-
Gilead SciencesCompletedChronic HCV InfectionBelgium, Austria, New Zealand, United Kingdom, Germany, Spain, Netherlands, France, Switzerland, Canada, Australia, Italy
-
Luzerner KantonsspitalCompletedRetinal Disease | Eye DiseaseSwitzerland
-
University of ZurichCompletedStable Coronary Heart DiseaseSwitzerland
-
Cardiocentro TicinoMeditrial SrLUnknownCoronary Artery DiseaseSwitzerland
-
University Hospital Inselspital, BerneCompletedRetinal DiseaseSwitzerland
-
University of ZurichCompletedChronic Obstructive Pulmonary Disease (COPD)Switzerland